On Thursday, shares of West Pharmaceutical Services, Inc. (NYSE:WST) marked $223.36 per share versus a previous $216.51 closing price. With having a 3.16% gain, an insight into the fundamental values of West Pharmaceutical Services, Inc., investors would also find a great ally in the technical patterns of the stock movements showed in stock charts. WST showed a rise of 48.58% within its YTD performance, with highs and lows between $120.11 – $221.96 during the period of 52 weeks, compared to the simple moving average of 37.48% in the period of the last 200 days.
BofA/Merrill equity researchers changed the status of West Pharmaceutical Services, Inc. (NYSE: WST) shares from “Underperform” to a “Neutral” rating in the report published on April 24th, 2020. Other analysts, including BofA/Merrill, also published their reports on WST shares. BofA/Merrill repeated the rating from the previous report, marking WST under “Underperform” rating, in the report published on December 12th, 2019. Additionally, WST shares got another “Neutral” rating from BofA/Merrill. On May 1st, 2019, Jefferies Downgrade an Hold rating and increased its price target to $122. On the other hand, William Blair Initiated the “Outperform” rating for WST shares, as published in the report on April 23rd, 2019. BofA/Merrill seems to be going bullish on the price of WST shares, based on the price prediction for WST. Another “Neutral” rating came from Goldman.
The present dividend yield for WST owners is set at 0, marking the return investors will get regardless of the company’s performance in the upcoming period. However, in order for the company to be able to pay its dividends, just like it is the case with West Pharmaceutical Services, Inc., the company needs to provide a healthy cash flow, currently at the value of 80.22. In addition, the growth of sales from quarter to quarter is recording 10.80%, hinting the company’s progress in the upcoming progress.
In order to gain a clear insight on the performance of West Pharmaceutical Services, Inc. (WST) as it may occur in the future, there are more than several well-rounded types of analysis and research techniques, while equity is most certainly one of the more important indicators into the company’s growth and performance. In this case, you want to make sure that the return on the present equity of 17.40% is enough for you to make a profit out of your investment. You may also count in the quick ratio of the company, currently set at 2.10 so you would make sure that the company is able to cover the debts it may have, which can be easily seen in annual reports of the company.
Set to affect the volatility of a given stock, the average volume can also be a valuable indicator, while WST is currently recording an average of 842.56K in volumes. The volatility of the stock on monthly basis is set at 3.21%, while the weekly volatility levels are marked at 2.79%with 5.04% of gain in the last seven days. Additionally, long-term investors are predicting the target price of $186.25, indicating growth from the present price of $223.36, which can represent yet another valuable research and analysis points that can help you decide whether to invest in WST or pass.
West Pharmaceutical Services, Inc. (WST) is based in the USA and it represents one of the well-known company operating with Healthcare sector. If you wish to compare WST shares with other companies under Electronic Equipment and Consumer Goods, a factor to note is the P/E value of 64.67 for West Pharmaceutical Services, Inc., while the value 55.23 can represent an indicator in the future growth of the company in terms of investor’s expectations. The later value should have a steady growth rate, increasing and growing gradually, which serves the purpose of reliably showcasing the progress of the company. The value 3.45 is supported by the yearly EPS growth of 18.20%.
Besides from looking into the fundamentals, you should also note the number of people inside the company owning the shares, as the values should be in line with the expectations of investors. In that spirit, the present ownership of stocks inside the company is set at 0.60%, which can provide you with an insight of how involved executives are in owning shares of the company. In oppose to the executives’ share, the institutional ownership counts 93.40% of shares, carrying an equal significance as an indicator of value, as the presence of large investors may signal a strong company.Are Institutional Investors Increasing Stakes in WST Shares?
It appears that more than several institutional investors and hedge funds decided to increase stakes in WST in the recent period. That is how The Vanguard Group, Inc. now has an increase position in WST by 1.45% in the first quarter, owning 7.54 million shares of WST stocks, with the value of $1.63 billion after the purchase of an additional 108,088 shares during the last quarter. In the meanwhile, SSgA Funds Management, Inc. also increased their stake in WST shares changed 1.96% in the first quarter, which means that the company now owns 2.79 million shares of company, all valued at $602.24 million after the acquisition of additional 53,552 shares during the last quarter.
WCM Investment Management LLC acquired a new position in West Pharmaceutical Services, Inc. during the first quarter, with the value of $304.79 million, and Artisan Partners LP increased their stake in the company’s shares by 9.04% in the first quarter, now owning 99,512 shares valued at $259.37 million after the acquisition of the additional 1.2 million shares during the last quarter. At the present, 93.40% of WST shares are in the ownership of institutional investors.